Compare BioNano Genomics Inc (BNGO) vs Global X Robotics and Artificial Intelligence ETF (BOTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Global X Robotics and Artificial Intelligence ETF — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Global X Robotics and Artificial Intelligence ETF trades at $37.87. The key difference: Global X Robotics and Artificial Intelligence ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | BOTZ | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | — |
52-Week High | $4.92 | $41.63 |
52-Week Low | $1.06 | $31.99 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.19, up 2.59% today, with bullish technical signals from moving averages. The company shows improving financials with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable. Recent earnings have consistently beaten expectations, and analyst sentiment is positive with 57% buy ratings. Key developments include debt retirement and scientific publications highlighting optical genome mapping adoption.
The outlook is cautiously optimistic given improving fundamentals and positive analyst coverage, but significant risks remain due to persistent losses and negative cash flow. Investment opportunity lies in the company's technology adoption growth, while primary risks include profitability challenges and competitive pressures in the genomics space.
BOTZ trades at $37.85, up 1.15% today, with a bullish technical signal from moving averages. The ETF's RSI levels suggest overbought conditions, while ADX indicates a strong trend. Recent news highlights its role in robotics and AI investing, with a focus on global tech exposure beyond U.S. markets.
Outlook remains positive due to thematic growth in robotics and AI, supported by institutional interest. Risks include sector volatility and competition from other ETFs. The dividend of $0.02 scheduled for July 2026 adds income appeal, but valuation metrics are unavailable for deeper analysis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Global X Robotics and Artificial Intelligence ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →
